Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD

Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD

Saved in:
Bibliographic Details
Main Authors: Mia Jensen, Steffen F. Nielsen, Steffen Thiel, Søren W.K. Hansen, Yaseelan Palarasah, Per Svenningsen, Jesper N. Bech, Frank H. Mose, Boye L. Jensen
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Kidney International Reports
Subjects:
kidney injury
lectin cascade
type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924020357
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2468-0249

Similar Items